0001288123-18-000009.txt : 20180622
0001288123-18-000009.hdr.sgml : 20180622
20180622113008
ACCESSION NUMBER: 0001288123-18-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180620
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buell Jennifer
CENTRAL INDEX KEY: 0001711184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 18913684
BUSINESS ADDRESS:
BUSINESS PHONE: 781-674-4400
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-06-20
0
0001098972
AGENUS INC
AGEN
0001711184
Buell Jennifer
3 FORBES ROAD
LEXINGTON
MA
02421
0
1
0
0
Chief Communications Officer
Common Stock, right to buy
5.65
2018-06-20
4
A
0
150000
5.65
A
2019-03-02
2028-03-02
Common Stock
150000
150000
D
Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 equity Inventive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.
Christine M. Klaskin, by Power of Attorney
2018-06-22